Bea Arthur
Maude Findlay
Search results
Cast
Episode Guide
- 1. Maude's Problem Sep 12, 1972
- Maude resents Carol's psychoanalysis; guest Ed Begley Jr.
- 2. Doctor, Doctor Sep 19, 1972
- Maude and Arthur declare war on each other when their grandchildren are caught playing doctor.
- 3. Maude Meets Florida Sep 26, 1972
- Maude hires a black housekeeper and insists that they become close friends.
Maude is an American television sitcom that was originally broadcast on the CBS network from September 12, 1972, until April 22, 1978. The show was the first spin-off of All in the Family, on which Bea Arthur had made two appearances as Maude Findlay, Edith Bunker 's favorite cousin.
Maude offers fairly-priced, thoughtfully-made devices, body care products and supplements for solo or shared pleasure. Shop online for vibes, rings, plugs, lubes, gummies, oils, candles and more.
Jun 30, 2024 · MAUDE is a database of adverse events involving medical devices reported to the FDA by manufacturers, importers, user facilities and others. Search MAUDE by product, event, date, brand name, manufacturer and more.
Maude: Created by Norman Lear. With Bea Arthur, Bill Macy, Conrad Bain, Adrienne Barbeau. "All In The Family" spin-off centered around Edith's cousin, Maude Findlay, a liberal, independent woman living in Tuckahoe, New York.
- (4.7K)
- 1972-09-12
- Comedy
- 30
From Season 1, Episode 1 'Maude's Problem' - Maude, a woman who believes in fighting city hall -- or anything else in her path -- tangles with a psychiatrist who is treating her daughter....
- 26 min
- 498.8K
- The Norman Lear Effect
Mar 4, 2024 · Maude enjoyed high ratings in its first four years, but in the 5th season, the sitcom dropped from No. 4 to No. 31. Bea Arthur announced she was leaving after the sixth season,...
People also ask
What does Maude stand for?
Why is Maude so popular?
When did Maude start?
What happened to Maude?
The Manufacturer and User Facility Device Experience (MAUDE) database contains medical device reports (MDRs) of adverse events. To further promote transparency, the FDA has begun...
